drugset / Trial / NCT01624246

Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance

NCT01624246

Phase 1 Completed 12 enrolled Forest Laboratories
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the pharmacokinetic (PK) profiles of ceftaroline and avibactam in adults with augmented renal clearance (ARC).

Timeline

Start
2012-05
Primary completion
2013-03
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ceftaroline fosamil Other / unclassified 600 mg Intravenous
Subject avibactam Small molecule 600 mg Intravenous

Indications

No indication recorded.